MedPath

Comparison the Effects of Dexamethasone and Loteprednol on Epithelial Healing

Phase 4
Completed
Conditions
Epithelial Defect After Phototherapeutic Keratectomy
Interventions
Registration Number
NCT01724892
Lead Sponsor
Khon Kaen University
Brief Summary

Corticosteroid has been used for the treatment after phototherapeutic keratectomy (PRK). Dexamethasone, a potent steroid can retard the corneal epithelial healing rate and has numerous serious complications, especially glaucoma. Loteprednol, a new generation of corticosteroid has less potency than dexamethasone and was proposed to has less side effect regarding intraocular pressure (IOP) elevation. Therefore, Investigators would like to compare the effect of dexamethasone and loteprednol on corneal epithelial healing rate after PRK and risk of glaucoma.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria
  • the patient with epithelial defect after phototherapeutic keratectomy
Exclusion Criteria
  • the patient with systemic disease such as diabetes and connective tissue disease
  • the patient with ocular surface disease such as dry eye and recurrent corneal erosion

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Loteprednol etabonateDexamethasoneTopical Loteprednol etabonate eye drop 0.5%, 4 times a day, 3 weeks
DexamethasoneLoteprednol etabonateTopical Dexamethasone eye drop 0.1%, 4 times a day, 3 weeks
Primary Outcome Measures
NameTimeMethod
corneal epithelial healing1 month
Secondary Outcome Measures
NameTimeMethod
intraocular pressure6 month

Trial Locations

Locations (2)

Onsiri Thanathanee

🇹🇭

Khon Kaen, Thailand

Srinagarind Hospital

🇹🇭

Khon Kaen, Thailand

© Copyright 2025. All Rights Reserved by MedPath